#TeamDrew

RESEARCH

#TeamDrew

RESEARCH

So, why is funding research for ultra-rare childhood cancers so important?

Only £3 in every £100 spent on cancer research goes to childhood cancers. Treatment options, cure rates and research for paediatric chordoma fall well beneath other childhood cancers.

When we set up the DBW Charity as a legacy to our little boy, we felt passionately about funding specific projects to help progress chordoma research and improve the chances of survival for other children and their families.

To discover what research has been undertaken from our donation please click the year below:

2019 – Funding in-depth genomic molecular characterisation of two paediatric chordoma cell lines and PDX models.

2018  – Funding the study into the genetic, epigenetic and transcriptomic changes found in the chordoma’s of children and adults.

The Drew Barker-Wright Charity continues to raise funds to support this ongoing project. It is only with your help and support that such research can continue. Together, it’s the only way

To be put in touch with Professor Adrienne Flanagan and her team directly, to make sure they are aware of your child’s diagnosis, please contact their coordinator at The Royal National Orthopaedic Hospital. 

Biobank and Chordoma Coordinator

E: rno-tr.histopathology@nhs.net T: 0208 909 5347

What is chordoma?

Read more >

Symptoms and diagnosis

Read more >

How you might be affected following your child’s diagnosis

Read more >

How and where is chordoma treated?

Read more >

If your child needs help with feeding during their treatment 

Read more >

After treatment

Read more >

If treatment fails

Read more >

Research

Read more >

Support

Read more >